Results 151 to 160 of about 2,013,224 (205)
Some of the next articles are maybe not open access.
Cutaneous manifestations of the malignant carcinoid syndrome
British Journal of Dermatology, 2005The incidence of carcinoid tumours is approximately 1.5 per 100 000 of the population. The malignant carcinoid syndrome, which is caused by circulating neuroendocrine mediators produced by the tumour, occurs in less than 10% of patients. Cutaneous involvement, although recognized in this rare syndrome, has rarely been reported.To examine a series of ...
H K, Bell +3 more
openaire +4 more sources
Treatment of the carcinoid tumor and the malignant carcinoid syndrome.
Certainly in treatment of the carcinoid tumor surgery has a well-established curative and palliative potential. The primary challenge is a knowledgable marriage between stage of disease and aggressiveness of operative procedure. Nonsurgical treatment of the malignant disease per se has thus far not produced optimum results and, in the opinion of this ...
C G Moertel
openaire +3 more sources
Results of Pharmacologic Treatment in the Malignant Carcinoid Syndrome
New England Journal of Medicine, 1962THE patient with the malignant carcinoid syndrome is confronted with a group of uncomfortable and debilitating symptoms. These may include recurrent acute flushing, colicky abdominal pains, violent and profuse watery diarrhea, tachycardia, asthma-like wheezing and, less often, profound weakness, depression or agitation, dyspnea and dependent edema ...
A L, URELES, M, MURRAY, R, WOLF
openaire +4 more sources
Diagnosis and Treatment of Malignant Carcinoid Syndrome
JAMA: The Journal of the American Medical Association, 1974THE malignant carcinoid syndrome has challenged the skills of the clinician, biochemist, and pharmacologist since its original description by Biorck et al 1 22 years ago. Although attention originally centered on a symptom complex and a serotonin-producing midintestinal neoplasm that had metastasized to the liver, the carcinoid syndrome has now been ...
openaire +4 more sources
The malignant carcinoid syndrome
The American Journal of Digestive Diseases, 1966openaire +4 more sources
Treatment of the Malignant Carcinoid Syndrome
Survey of Anesthesiology, 1986Larry K. Kvols +5 more
openaire +3 more sources
Archives of Surgery, 1959
The malignant carcinoid syndrome is manifested by (1) paroxysmal flushing, (2) chronic diarrhea, (3) respiratory distress, and (4) valvular heart disease. These abnormalities result from a marked increase in the amount of circulating serotonin. The abnormal clinical findings in this syndrome result principally from the action of serotonin on the ...
Wilson, Harwell, Storer, Edward H.
openaire +3 more sources
The malignant carcinoid syndrome is manifested by (1) paroxysmal flushing, (2) chronic diarrhea, (3) respiratory distress, and (4) valvular heart disease. These abnormalities result from a marked increase in the amount of circulating serotonin. The abnormal clinical findings in this syndrome result principally from the action of serotonin on the ...
Wilson, Harwell, Storer, Edward H.
openaire +3 more sources
Therapy of the Malignant Carcinoid Syndrome
Endocrinology and Metabolism Clinics of North America, 1989Although usually associated with carcinoid tumors of the small intestine that have metastasized to the liver, the carcinoid syndrome is seen less frequently with primary tumors arising from other organs such as the lung, pancreas, thymus, stomach, and ovary.
openaire +2 more sources

